(Q44291160)

English

Expansion of highly differentiated CD8+ T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647156%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Expansion of highly differentiated CD8+ T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647156%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

0 references

Cytomegalovirus

0 references

dasatinib monohydrate

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647156%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647156%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647156%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647156%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647156%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

C Koechel

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647156%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

E Gostick

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647156%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

M Ekblom

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647156%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

L Stenke

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647156%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

T Melo

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647156%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

H Einsele

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647156%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

R Seggewiss

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647156%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

publication date

7 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647156%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647156%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647156%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647156%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1587-1597

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21647156%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Profound inhibition of antigen-specific T-cell effector functions by dasatinib

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Dasatinib exerts an immunosuppressive effect on CD8+ T cells specific for viral and leukemia antigens

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Dasatinib inhibits recombinant viral antigen-specific murine CD4+ and CD8+ T-cell responses and NK-cell cytolytic activity in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Nilotinib hampers the proliferation and function of CD8+ T lymphocytes through inhibition of T cell receptor signalling

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Nilotinib inhibits the Src-family kinase LCK and T-cell function in vitro

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Natural killer or natural killer/T cell lineage large granular lymphocytosis associated with dasatinib therapy for Philadelphia chromosome positive leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Sprycel for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to or intolerant of imatinib mesylate

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Role of the production of natural killer cell stimulatory factor (NKSF/IL-12) in the ability of B cell lines to stimulate T and NK cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Biophotonic cytotoxicity assay for high-throughput screening of cytolytic killing

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Phenotypic differences between healthy effector CTL and leukemic LGL cells support the notion of antigen-triggered clonal transformation in T-LGL leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Phenotype and function of human T lymphocyte subsets: consensus and issues

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Adaptive immune features of natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Cytokine-induced memory-like natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Intermittent target inhibition with dasatinib 100 mg once daily preserves efficacy and improves tolerability in imatinib-resistant and -intolerant chronic-phase chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Immunoprofiling of patients with chronic myeloid leukemia at diagnosis and during tyrosine kinase inhibitor therapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Features of large granular lymphocytes (LGL) expansion following allogeneic stem cell transplantation: a long-term analysis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Transient monoclonal expansion of CD8+/CD57+ T-cell large granular lymphocytes after primary cytomegalovirus infection.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Oligoclonal T cell receptor gene rearrangements in blood lymphocytes of patients with acute Epstein-Barr virus-induced infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Direct ex vivo analysis reveals distinct phenotypic patterns of HIV-specific CD8(+) T lymphocyte activation in response to therapeutic manipulation of virus load

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Generation of CD3+CD8low thymocytes in the HIV type 1-infected thymus

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Chronic gene delivery of interferon-inducible protein 10 through replication-competent retrovirus vectors suppresses tumor growth.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

CCR1/CCL5 (RANTES) receptor-ligand interactions modulate allogeneic T-cell responses and graft-versus-host disease following stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Constitutive activation of Lck and Fyn tyrosine kinases in large granular lymphocytes infected with the gamma-herpesvirus agents of malignant catarrhal fever

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

High avidity myeloid leukemia-associated antigen-specific CD8+ T cells preferentially reside in the bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Clonal expansions of cytotoxic T cells exist in the blood of patients with Waldenstrom macroglobulinemia but exhibit anergic properties and are eliminated by nucleoside analogue therapy.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

21 January 2018

Survival after bone marrow transplantation from cytomegalovirus seropositive sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

7 January 2021

based on heuristic

inferred from DOI database lookup

Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8 + CD57 + CD28 − compartment

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.135

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44291160&oldid=2206547187"